This presentation is under embargo until Wed 4 Feb, as per congress regulations

Publication
  • EAHAD •
  • 6 February, 2026 •
  • •

Efanesoctocog Alfa Prophylaxis for People with Severe Haemophilia A: Third Interim Results from the XTEND-ed Long-Term Extension Study

Sophie Susen, Anthony KC Chan, Pratima Chowdary, Stephanie P’ng, Manuela Albisetti, Keiji Nogami, Karin Fijnvandraat, Jennifer Dumont , Elena Santagostino, Sriya Gunawardena, Mahnouch Georget, Lynn Malec

Publication
  • EAHAD •
  • 4 February, 2026 •
  • •

Physical Activity and Efficacy in Patients with Severe Haemophilia A Treated with Efanesoctocog Alfa: 12-Month Interim Results from FREEDOM

Jan Astermark, Olga Benitez Hidalgo, Hervé Chambost, Antonio Coppola, Shamil Sadikhov, Jenny Björkqvist, Markus Fusser, Niamh O’Connell

Publication
  • EAHAD •
  • 4 February, 2026 •
  • •

Long-Term Clinical Outcomes of Efanesoctocog Alfa in Patients with Severe Haemophilia A: European Results from the Third Interim Analysis of XTEND-ed

Sophie Susen, Manuela Albisetti, Karin Fijnvandraat, Elena Santagostino, Mahnouch Georget, Meredith C. Foster, Pratima Chowdary

Sign up for alerts